Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.

Chengjun Jiang,Hangxiang Wang,Xiaomin Zhang,Zhibin Sun,Feng Wang,Jun Cheng,Haiyang Xie,Bo Yu,Lin Zhou
DOI: https://doi.org/10.1016/j.ijpharm.2014.08.037
IF: 6.51
2014-01-01
International Journal of Pharmaceutics
Abstract:Polymeric micelles hold great promise in nanocarrier delivery systems for anticancer drugs. A mixed micelle composed of deoxycholic acid-modified chitooligosaccharide (COS-DOCA) and methoxy poly(ethylene glycol)-polylactide copolymer (mPEG-PDLLA) was designed and synthesized for encapsulation of paclitaxel. The PTX-loaded mixed micelles have high drug-loading efficiency and encapsulation efficiency as well as small size (∼40nm) and narrow size distribution. The PTX-loaded COS-DOCA/mPEG-PDLLA mixed micelles showed the enhanced antitumor efficacy in A549 lung xenograft model.
What problem does this paper attempt to address?